CPC A61K 31/4045 (2013.01) [C07B 2200/05 (2013.01)] | 9 Claims |
1. A deuterium-enriched N,N-dimethyltryptamine mixture consisting essentially of:
N,N-dimethyltryptamine, including pharmaceutically acceptable salts thereof; and
50% or more by weight in total of α-protio, α-deutero-N,N-dimethyltryptamine of the formula
![]() including pharmaceutically acceptable salts thereof; and
α,α-dideutero-N,N-dimethyltryptamine of the formula
![]() including pharmaceutically acceptable salts thereof;
wherein the mixture comprises 2% or more by weight of the α-protio, α-deutero-N,N-dimethyltryptamine, including pharmaceutically acceptable salts thereof; and
wherein the deuterium-enriched N,N-dimethyltryptamine mixture has a purity of greater than or equal to 99% by HPLC.
|